# Transcatheter Treatment of Tricuspid Valve Regurgitation

> **NCT06093828** · NA · NOT_YET_RECRUITING · sponsor: **TriFlo Cardiovascular, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Symptomatic Severe Tricuspid Regurgitation

## Interventions

- **DEVICE:** TriFlo Tricuspid Flow Optimizer

## Key facts

- **NCT ID:** NCT06093828
- **Lead sponsor:** TriFlo Cardiovascular, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10
- **Primary completion:** 2027-01
- **Final completion:** 2031-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06093828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06093828, "Transcatheter Treatment of Tricuspid Valve Regurgitation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06093828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*